Digital Heart Twins Revolutionize Treatment for Deadly Arrhythmias

A groundbreaking study has shown how digital replicas of patients' hearts could transform treatment for dangerous heart rhythms. Researchers at Johns Hopkins University created these virtual models to guide procedures with remarkable success. The findings, published in the New England Journal of Medicine, suggest a major step forward in cardiac care. The trial, named TWIN-VT, involved 10 patients who had suffered heart attacks and developed ventricular tachycardia—a life-threatening arrhythmia. Each participant had a digital twin of their heart built from detailed scans and medical data. These virtual models allowed doctors to test and refine ablation procedures before performing them on the real heart.

The approach led to faster, more precise treatments. Surgeons used the digital twins to pinpoint the best targets for ablation, achieving a 100% success rate. After more than a year, all 10 patients remained free of arrhythmias—far exceeding the 60% long-term success rate seen with traditional methods. Beyond immediate results, the technology helped reduce reliance on medication. Eight patients stopped taking anti-arrhythmia drugs entirely, while the remaining two cut their doses. The digital twins also predicted whether arrhythmias might return, giving doctors clearer guidance on follow-up care. Encouraged by these outcomes, the team now plans larger trials. They aim to expand the use of cardiac digital twins to other heart conditions, potentially improving treatment for a wider range of patients.

The study's results highlight the potential of digital twins to make cardiac procedures safer and more effective. With no recurrences in over a year, the method outperformed standard treatments. Further trials will determine whether this technology can become a routine part of heart care.